183 related articles for article (PubMed ID: 32152924)
41. Fraxin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting the NF-κB and NLRP3 signalling pathways.
Li W; Li W; Zang L; Liu F; Yao Q; Zhao J; Zhi W; Niu X
Int Immunopharmacol; 2019 Feb; 67():1-12. PubMed ID: 30530164
[TBL] [Abstract][Full Text] [Related]
42. Anti-inflammatory effects of water extract of Taraxacum mongolicum hand.-Mazz on lipopolysaccharide-induced inflammation in acute lung injury by suppressing PI3K/Akt/mTOR signaling pathway.
Ma C; Zhu L; Wang J; He H; Chang X; Gao J; Shumin W; Yan T
J Ethnopharmacol; 2015 Jun; 168():349-55. PubMed ID: 25861954
[TBL] [Abstract][Full Text] [Related]
43. Levobupivacaine attenuates lipopolysaccharide-induced acute lung injury.
Guo D; Li K; Yang M; Zhang H; Miao Y
Fundam Clin Pharmacol; 2016 Aug; 30(4):307-15. PubMed ID: 26991027
[TBL] [Abstract][Full Text] [Related]
44. Study the mechanism of peimisine derivatives on NF-κB inflammation pathway on mice with acute lung injury induced by lipopolysaccharide.
Jin X; Gao X; Lan M; Li CN; Sun JM; Zhang H
Chem Biol Drug Des; 2022 May; 99(5):717-726. PubMed ID: 34939324
[TBL] [Abstract][Full Text] [Related]
45. Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells.
Luo Y; Che W; Zhao M
Int J Mol Med; 2017 Feb; 39(2):297-306. PubMed ID: 27959396
[TBL] [Abstract][Full Text] [Related]
46. Erlotinib Protects LPS-Induced Acute Lung Injury in Mice by Inhibiting EGFR/TLR4 Signaling Pathway.
Tao H; Li N; Zhang Z; Mu H; Meng C; Xia H; Fu L; Xu Y; Zhang S
Shock; 2019 Jan; 51(1):131-138. PubMed ID: 29438224
[TBL] [Abstract][Full Text] [Related]
47. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
48. Euphorbia factor L2 alleviates lipopolysaccharide-induced acute lung injury and inflammation in mice through the suppression of NF-κB activation.
Zhang Q; Zhu S; Cheng X; Lu C; Tao W; Zhang Y; William BC; Cao X; Yi S; Liu Y; Zhao Y; Luo Y
Biochem Pharmacol; 2018 Sep; 155():444-454. PubMed ID: 30055150
[TBL] [Abstract][Full Text] [Related]
49. Genipin attenuates mitochondrial-dependent apoptosis, endoplasmic reticulum stress, and inflammation via the PI3K/AKT pathway in acute lung injury.
Luo X; Lin B; Gao Y; Lei X; Wang X; Li Y; Li T
Int Immunopharmacol; 2019 Nov; 76():105842. PubMed ID: 31466050
[TBL] [Abstract][Full Text] [Related]
50. The novel N-methyl-d-aspartate receptor antagonist MN-08 ameliorates lipopolysaccharide-induced acute lung injury in mice.
Jiang J; Jian Q; Jing M; Zhang Z; Zhang G; Shan L; Yu P; Wang Y; Xu L
Int Immunopharmacol; 2019 Jan; 66():109-118. PubMed ID: 30447529
[TBL] [Abstract][Full Text] [Related]
51. Isovitexin Exerts Anti-Inflammatory and Anti-Oxidant Activities on Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting MAPK and NF-κB and Activating HO-1/Nrf2 Pathways.
Lv H; Yu Z; Zheng Y; Wang L; Qin X; Cheng G; Ci X
Int J Biol Sci; 2016; 12(1):72-86. PubMed ID: 26722219
[TBL] [Abstract][Full Text] [Related]
52. Citral inhibits lipopolysaccharide-induced acute lung injury by activating PPAR-γ.
Shen Y; Sun Z; Guo X
Eur J Pharmacol; 2015 Jan; 747():45-51. PubMed ID: 25281205
[TBL] [Abstract][Full Text] [Related]
53. Cyanidin-3-O-β-glucoside ameliorates lipopolysaccharide-induced acute lung injury by reducing TLR4 recruitment into lipid rafts.
Fu Y; Zhou E; Wei Z; Wang W; Wang T; Yang Z; Zhang N
Biochem Pharmacol; 2014 Jul; 90(2):126-34. PubMed ID: 24841888
[TBL] [Abstract][Full Text] [Related]
54. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro.
Jing W; Chunhua M; Shumin W
Toxicol Appl Pharmacol; 2015 Jun; 285(2):128-35. PubMed ID: 25902336
[TBL] [Abstract][Full Text] [Related]
55. Timosaponin B-II inhibits lipopolysaccharide-induced acute lung toxicity via TLR/NF-κB pathway.
Zhang T; Wang J; Wang S; Ma C
Toxicol Mech Methods; 2015; 25(9):665-71. PubMed ID: 26540118
[TBL] [Abstract][Full Text] [Related]
56. Atractylenolide I protects mice from lipopolysaccharide-induced acute lung injury.
Zhang JL; Huang WM; Zeng QY
Eur J Pharmacol; 2015 Oct; 765():94-9. PubMed ID: 26297303
[TBL] [Abstract][Full Text] [Related]
57. Topotecan Alleviates Lipopolysaccharide-Mediated Acute Lung Injury Via the NF-κB Signaling Pathway.
Jin J; Xu W; Wan B; Wang X; Zhou Z; Miao Y; Lv T; Song Y
J Surg Res; 2019 Mar; 235():83-92. PubMed ID: 30691855
[TBL] [Abstract][Full Text] [Related]
58. Fucosterol attenuates lipopolysaccharide-induced acute lung injury in mice.
Li Y; Li X; Liu G; Sun R; Wang L; Wang J; Wang H
J Surg Res; 2015 May; 195(2):515-21. PubMed ID: 25818525
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-92a antagonism attenuates lipopolysaccharide (LPS)-induced pulmonary inflammation and injury in mice through suppressing the PTEN/AKT/NF-κB signaling pathway.
Fu L; Zhu P; Qi S; Li C; Zhao K
Biomed Pharmacother; 2018 Nov; 107():703-711. PubMed ID: 30138892
[TBL] [Abstract][Full Text] [Related]
60. Soyasaponin Ab inhibits lipopolysaccharide-induced acute lung injury in mice.
Lin J; Cheng Y; Wang T; Tang L; Sun Y; Lu X; Yu H
Int Immunopharmacol; 2016 Jan; 30():121-128. PubMed ID: 26672918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
